Skip to main content
Log in

Foudroyant verlaufendes malignes Melanom bei Urticaria pigmentosa

Aggressive malignant melanoma in a patient with urticaria pigmentosa

  • Diaklinik
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Abbreviations

MELTUMP:

„Melanocytic tumour of uncertain malignant potential“

SSM:

Superfiziell spreitendes malignes Melanom

Literatur

  1. Cerroni L, Barnhill R, Elder D, Gottlieb G, Heenan P, Kutzner H, LeBoit PE, Mihm M Jr, Rosai J, Kerl H (2010) Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 34:314–326

    Article  PubMed  Google Scholar 

  2. Hägglund H, Sander B, Gülen T, Lindelöf B, Nilsson G (2014) Increased risk of malignant melanoma in patients with systemic mastocytosis? Acta Derm Venereol 94:583–584

    Article  PubMed  Google Scholar 

  3. Molderings GJ, Zienkiewicz T, Homann J, Menzen M, Afrin LB (2017) Risk of solid cancer in patients with mast cell activation syndrome: results from Germany and USA. F1000Res 26:1889

    Article  Google Scholar 

  4. Paolino G, Belmonte M, Trasarti S, Santopietro M, Bizzoni L, Riminucci M, Cardarelli L, Iannella E, Albanesi M, Moliterni E, Didona D, Calvieri S, Foà R, Giona F (2017) Mast cell disorders, melanoma and pancreatic carcinoma: from a clinical observation to a brief review of the literature. Acta Dermatovenerol Croat 25:112–119

    PubMed  Google Scholar 

  5. Todd P, Garioch J, Seywright M, Rademaker M, Thomson J (1991) Malignant melanoma and systemic mastocytosis – a possible association? Clin Exp Dermatol 16:455–457

    Article  PubMed  CAS  Google Scholar 

  6. Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD (2017) Advances in the classification and treatment of mastocytosis: current status and outlook toward the future. Cancer Res 77:1261–1270

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristel Ruini.

Ethics declarations

Interessenkonflikt

C. Ruini, D. Hartmann, M.J. Flaig, T. von Braunmühl und C. Berking geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

This article is part of a supplement sponsored by LEO Pharma GmbH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruini, C., Hartmann, D., Flaig, M.J. et al. Foudroyant verlaufendes malignes Melanom bei Urticaria pigmentosa. Hautarzt 69 (Suppl 1), 45–48 (2018). https://doi.org/10.1007/s00105-018-4220-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-018-4220-8

Navigation